BDBM799712 US12583853, Compound Example 2::6-(4-[[2-(4-chlorophenyl)-4,4-dimethylcyclohex-1-en-1-yl]methyl]piperazin-1-yl)-2-(4-[[(2S)-1,4-dioxan-2-ylmethyl]amino]-3-nitrobenzenesulfonyl)-4-[1H-pyrrolo[2,3-b]pyridin-5-yl]-3,4-dihydroisoquinolin-1-one

SMILES CC9(C)CCC(CN7CCN(C1C=C4C(=CC1)C(=O)N(S(=O)(=O)c3ccc(NC[C@H]2COCCO2)c([N+](=O)[O-])c3)CC4C6C=c5cc[nH]c5=NC6)CC7)=C(c8ccc(Cl)cc8)C9

InChI Key

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 799712   

TargetApoptosis regulator Bcl-2(Human)
Newave Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 799712BDBM799712(US12583853, Compound Example 2 | 6-(4-[[2-(4-chlor...)
Affinity DataIC50: 0.800nMAssay Description:Cytokinesis is a cell-based assay to assess nonmuscle myosin II function, performed using COS7 cells. The assay is run in a 96 well plate, with 2,000...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/3/2026
Entry Details
US Patent